Search

Pharynx / Larynx Cancer

C051

COMPARING MUTATIONAL PROFILES OF RESPONDERS AND NON-RESPONDERS CELL-FREE CIRCULATING TUMOR DNA IN OROPHARYNGEAL SQUAMOUS CELL CARCINOMA PATIENTS

Pharynx / Larynx Cancer

Mickie J Hamiter, MD1, Adam H Greer, PhD2, Rhett Orgeron1, Alok R Khandelwal, PhD1, Xiaohui Ma1, Tara Moore-Medlin1, Hong Yin, MDPhD2, Glenn Mills, MD2, Cherie-Ann O Nathan, MD1

1LSU Health Shreveport, 2Feist Weiller Cancer Center


C052

LARYNGEAL CANCER TREATMENT AND OUTCOMES IN THE UNDER AND UNINSURED: A 10 YEAR REVIEW

Pharynx / Larynx Cancer

Tanner M Fullmer, MD, David M Wilde, Susan A Eicher, MD, Nadia G Mohyuddin, MD, Andrew G Sikora, MD, PhD, Vlad C Sandulache, MD, PhD

Baylor College of Medicine Bobby R. Alford Department of Otolaryngology


C053

A GERMLINE VARIANT IN JAK3 AS A POTENTIAL BIOMARKER OF LARYNGEAL CANCER RISK IN AFRICAN AMERICANS

Pharynx / Larynx Cancer

Jean-Nicolas Gallant, PhD1, Aliya Gifford, PhD1, Janey Wang, MS1, Rafael Guerrero, PhD2, Young Kim, MD, PhD1

1Vanderbilt University, 2University of Puerto Rico


C054

CT TEXTURE ANALYSIS WITH MACHINE LEARNING FOR THE PREDICTION OF DISEASE SITE ASSOCIATED FEATURES AND NODAL STATUS FOR HEAD AND NECK SQUAMOUS CELL CARCINOMA

Pharynx / Larynx Cancer

Xiaoyang Liu1, Eugene Yu1, Behzad Forghani2, Almudena Perez-Lara2, Shao Hui Huang1, John Waldron1, Brian O'Sullivan1, Eric Bartlett1, Mark Levental2, Thomas Ong2, Maryam Bayat2, Reza Forghani2

1University of Toronto, 2McGill University


C055

OPTIMIZED PRIMER/PROBE SETS FOR HPV-16 DETECTION IN HEAD AND NECK CARCINOMA

Pharynx / Larynx Cancer

Yuki Saito, MD, PhD1, Alexander V Favorov, PhD2, Shuling Ren, MD1, Akihiro Sakai, MD, PhD1, Takahito Fukusumi, MD, PhD1, Mizuo Ando, MD, PhD3, Chao Liu, MD1, Joseph A Califano, MD1

1Moors Cancer Center, University of California San Diego, 2Division of Oncology Biostatistics and Bioinformatics, Sidney Kimmel Comprehensive Cancer Center, Department of Oncology, Johns Hopkins University, 3Otolaryngology-Head and Neck Surgery, University of Tokyo


C056

PHARYNGEAL CONSTRICTOR BOTULINUM TOXIN INJECTION THERAPY FOR APHONIA AND DYSPHAGIA FOLLOWING TOTAL LARYNGECTOMY

Pharynx / Larynx Cancer

Shannon D Fayson, Laura Matrka, MD, Brad W deSilva, MD

The Ohio State University


C057

ONCOLOGIC OUTCOMES OF UNKNOWN PRIMARY SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK FOLLOWING TORS-BASED MANAGEMENT

Pharynx / Larynx Cancer

John R Sims, MD, Kathryn M Van Abel, MD, Katharine A Price, MD, Daniel J Ma, MD, Daniel L Price, MD, Eric J Moore, MD

Mayo Clinic


C058

ASSESSMENT OF CB1 AND CB2 RECEPTORS IN HEAD AND NECK SQUAMOUS CELL CARCINOMA

Pharynx / Larynx Cancer

Kelly E Daniels, BS, Adam J Luginbuhl, MD, Andrew P South, PhD

Thomas Jefferson University


C059

ELECTIVE PARATRACHEAL NODE AT THE TIME OF SALVAGE LARYNGECTOMY IMPROVES LOCOREGIONAL DISEASE FREE SURVIVAL AND DISEASE SPECIFIC SURVIVAL FOR RECURRENT ADVANCED GLOTTIC SQUAMOUS CELL CARCINOMA

Pharynx / Larynx Cancer

Andrew C Birkeland, MD, Andrew J Rosko, MD, Catherine T Haring, MD, Josh D Smith, J Chad Brenner, PhD, Andrew G Shuman, MD, Steven B Chinn, MD, Chaz L Stucken, MD, Kelly M Malloy, MD, Jeffrey S Moyer, MD, Keith A Casper, MD, Mark E Prince, MD, Carol R Bradford, MD, Gregory T Wolf, MD, Douglas B Chepeha, MD, Matthew E Spector, MD

University of Michigan


C060

IMPACT OF NODAL YIELD AT A SINGLE INSTITUTION IN PATIENTS UNDERGOING NECK DISSECTION AND TOTAL LARYNGECTOMY

Pharynx / Larynx Cancer

Michael C Topf, MD, Linda C Magana, PhD, James Metkus, MD, James Hamilton, MD, Larissa Sweeny, MD, William M Keane, MD, Richard A Goldman, MD, Adam Luginbuhl, MD, Joseph M Curry, MD, David M Cognetti, MD

Thomas Jefferson University Hospital